Supreme Court Agrees With Drug Firms That 340B Providers Cannot Sue Over Prices
This article was originally published in The Pink Sheet Daily
Executive Summary
The federal government will have to take the lead on investigating and potentially punishing past overcharging for drugs as a result of the March 29 ruling.